KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Common Equity: 2009-2024

Historic Common Equity for Astrana Health (ASTH) over the last 16 years, with FY2024 value amounting to $716.7 million.

  • Astrana Health's Common Equity rose 1119.7% to $789.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $789.1 million, marking a year-over-year increase of 1119.7%. This contributed to the annual value of $716.7 million for FY2024, which is 1622.88% up from last year.
  • Astrana Health's Common Equity amounted to $716.7 million in FY2024, which was up 1622.88% from $616.7 million recorded in FY2023.
  • Over the past 5 years, Astrana Health's Common Equity peaked at $716.7 million during FY2024, and registered a low of $329.5 million during FY2020.
  • Over the past 5 years, Astrana Health's median Common Equity value was $544.3 million (recorded in 2022), while the average stood at $532.3 million.
  • As far as peak fluctuations go, Astrana Health's Common Equity surged by 7129.64% in 2020, and later surged by 1329.04% in 2023.
  • Astrana Health's Common Equity (Annual) stood at $329.5 million in 2020, then skyrocketed by 37.83% to $454.1 million in 2021, then rose by 19.86% to $544.3 million in 2022, then increased by 13.29% to $616.7 million in 2023, then grew by 16.23% to $716.7 million in 2024.
  • Its Common Equity stands at $716.7 million for FY2024, versus $616.7 million for FY2023 and $544.3 million for FY2022.